Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis
Clinical trial NCT01966783 · COMPLETED
Trial details
- NCT number
- NCT01966783
- Sponsor
- Dr. Falk Pharma GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-08-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.